The KEYNOTE-B96 study of pembrolizumab plus paclitaxel in recurrent platinum-resistant ovarian cancer has met its primary end ...

I had a couple of days off and then went back to the office. Life continued. It wasn’t until two years later, when I was ...

Bloating , thrush and lower back pain are all symptoms that most women will put down to hormonal changes at different stages of their menstrual cycle.

Merck (NYSE:MRK) announced Thursday that its bestselling therapy, Keytruda, as part of a combination regimen, reached the ...

Ovarian cancer, often diagnosed late due to subtle symptoms, sees significantly improved survival rates with early detection.

A cancer survivor is raising awareness about the importance of genetic testing. Why she believes it can be imperative to ...

In this video, Ursula A. Matulonis, MD, discusses new data on rinatabart sesutecan, or Rina-S, for patients with advanced ovarian cancer, which were presented at Society of Gynecologic Oncology Annual ...

In this video, Ursula A. Matulonis, MD, discusses results from the phase 3 MIRASOL trial of mirvetuximab soravtansine-gynx for patients with folate receptor alpha-positive, platinum-resistant ovarian ...

The U.S. Federal Drug Administration (FDA) has granted Incyclix Bio Fast Track designation for INX-315 to treat ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...